+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pathogen Screening Kits Market - Global Forecast 2026-2032- Product Image
Pathogen Screening Kits Market - Global Forecast 2026-2032- Product Image
New

Pathogen Screening Kits Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6277814
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Pathogen Screening Kits: Executive Overview

Pathogen screening kits support the detection and characterization of infectious agents across clinical diagnostics, food safety, environmental monitoring, biopharmaceutical manufacturing, and public-health programs. Their value is shaped by analytical sensitivity, specificity, turnaround time, workflow integration, multiplexing, sample compatibility, and the strength of quality systems. Demand is closely linked to preparedness, routine surveillance, infection-control requirements, and the need for faster evidence-based decisions.

Preparedness and Decentralization Are Reshaping Screening

The landscape is shifting from episodic testing toward continuous surveillance and earlier intervention. Public-health agencies, hospitals, laboratories, manufacturers, and food operators increasingly favor workflows that combine rapid screening with confirmatory testing, digital traceability, and standardized interpretation. Decentralized and near-patient formats can improve access and response speed, while centralized laboratories remain important for high-throughput testing, complex panels, quality assurance, and epidemiological characterization. Regulatory expectations, supply resilience, and interoperability are becoming strategic selection criteria alongside assay performance.

Artificial Intelligence Strengthens Interpretation and Operations

Artificial intelligence can amplify the value of pathogen screening kits by supporting image and signal interpretation, anomaly detection, assay development, sample triage, and quality-control monitoring. Machine-learning systems may help identify patterns across multidimensional or multiplex results and reduce manual review, provided that training data are representative and performance is independently validated. The principal constraints remain data quality, explainability, cybersecurity, privacy, workflow accountability, and the risk of automation bias. AI should therefore be deployed as a controlled decision-support layer with human oversight, documented validation, and continuous monitoring.

Regional Insights: Regulation, Access, and Surveillance Priorities

North America emphasizes laboratory quality, outbreak readiness, decentralized testing, and integration with clinical and public-health information systems. Europe combines stringent conformity expectations with cross-border surveillance and harmonized health priorities. Asia-Pacific presents varied laboratory capacity, strong manufacturing and research ecosystems, and significant needs for scalable screening across urban and rural settings. Latin America is shaped by uneven access, infectious-disease surveillance requirements, and the importance of robust distribution and training. The Middle East is strengthening healthcare infrastructure, travel-related screening, and centralized laboratory capabilities, while Africa continues to prioritize affordable access, supply continuity, decentralized diagnostics, and disease-surveillance networks.

Group Insights: Cooperation Shapes Adoption Requirements

ASEAN priorities center on regional health security, cross-border movement, laboratory-capacity development, and adaptable testing workflows. BRICS members reflect diverse disease burdens, domestic manufacturing objectives, and efforts to improve diagnostic resilience. The European Union places emphasis on coordinated surveillance, quality standards, data exchange, and public-health preparedness. G7 economies generally prioritize advanced laboratory systems, rapid innovation, regulatory rigor, and resilient supply chains. GCC markets focus on healthcare modernization, centralized procurement, travel and event preparedness, and workforce capability. NATO countries place particular importance on biological preparedness, interoperability, logistics, and secure continuity of critical testing services.

Country Insights: Diverse Operating Environments

Australia combines strong laboratory governance with geographic-access challenges and a focus on biosecurity and surveillance. Brazil requires solutions suited to a large, diverse territory and varied healthcare capacity. Canada emphasizes public-health coordination, remote access, and reliable laboratory networks. China combines substantial diagnostic infrastructure with domestic technology development and large-scale surveillance needs. France, Germany, Italy, Spain, and the United Kingdom operate within mature regulatory and healthcare environments where quality, interoperability, and preparedness are central. India balances high testing needs and expanding capacity with affordability, decentralization, and supply resilience. Japan prioritizes precision, quality assurance, and demographic-sensitive healthcare delivery. South Korea is recognized for digitally enabled health infrastructure and rapid-response capability. Mexico requires scalable access, regional distribution, and integration between public and private healthcare. Russia’s operating environment is shaped by domestic supply considerations, centralized capacity, and geographically dispersed service needs. The United States emphasizes regulatory compliance, laboratory performance, innovation, and preparedness across clinical, food, and environmental applications.

Actions for Leaders: Build Resilient, Validated Screening Systems

Industry leaders should segment solutions by use case rather than pursue a single universal workflow. Priorities include independent analytical and clinical validation, clear differentiation between screening and confirmation, broad sample-type testing, dependable controls, and transparent performance claims. Organizations should design for interoperability with laboratory information systems, maintain dual-source or regional supply options where feasible, and provide training that supports correct collection, handling, interpretation, and disposal. AI-enabled features should be introduced through documented governance, cybersecurity controls, bias testing, and human review. Partnerships with laboratories, health authorities, distributors, and end users can improve real-world fit while structured post-market surveillance can identify performance drift and emerging pathogens.

Research Methodology: Evidence-Led Market Assessment

The assessment uses a structured review of publicly available regulatory materials, peer-reviewed scientific literature, public-health guidance, laboratory standards, procurement and policy documents, and documented technology evidence. Findings are organized by application, workflow, technology characteristics, geography, and institutional context. Regional, group, and country comparisons consider surveillance priorities, healthcare infrastructure, laboratory capacity, regulatory conditions, access constraints, and supply-chain resilience. Claims are cross-checked for consistency, and qualitative conclusions are limited to evidence-supported patterns. The analysis does not rely on undisclosed assumptions or present market estimates, shares, sizing, or forecasts.

Conclusion: Performance and Resilience Define Long-Term Value

Pathogen screening kits are becoming integral to faster detection, routine surveillance, and operational risk management across healthcare and non-clinical settings. Success will depend on more than assay accuracy: usability, validated performance, regulatory alignment, digital integration, workforce readiness, and dependable supply are equally important. Regional and country conditions require adaptable deployment models, while AI offers meaningful gains only when governed responsibly. Leaders that combine scientific rigor with resilient operations and clear implementation support will be best positioned to translate screening capability into timely, trustworthy action.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Pathogen Screening Kits Market, by Technology
7.1. Introduction
7.2. Culture Based
7.2.1. Culture Enrichment Kits
7.2.2. Selective Media Kits
7.3. Immunoassay Based
7.3.1. Chemiluminescent Immunoassay
7.3.2. Enzyme Linked Immunosorbent Assay
7.3.3. Lateral Flow Assay
7.4. Isothermal Amplification
7.4.1. Helicase Dependent Amplification
7.4.2. Loop Mediated Isothermal Amplification
7.4.3. Recombinase Polymerase Amplification
7.5. Mass Spectrometry Based
7.5.1. LC MS MS
7.5.2. MALDI TOF
7.6. Microarray Based
7.6.1. DNA Microarray
7.6.2. Protein Microarray
7.7. Next Generation Sequencing Based
7.7.1. Amplicon Sequencing
7.7.2. Shotgun Metagenomics
7.7.3. Targeted Sequencing
7.8. PCR Based
7.8.1. Digital PCR
7.8.2. Quantitative PCR
7.8.3. Real Time PCR
7.8.4. Reverse Transcription PCR
8. Pathogen Screening Kits Market, by Product Type
8.1. Introduction
8.2. Consumables And Reagents
8.2.1. Controls And Standards
8.2.2. Enzymes And Master Mixes
8.2.3. Extraction Kits
8.2.4. Reagent Kits
8.3. Instruments And Platforms
8.3.1. Automated Extraction Systems
8.3.2. Lateral Flow Readers
8.3.3. Real Time PCR Instruments
8.3.4. Sequencers
8.3.5. Thermal Cyclers
8.4. Services
8.4.1. Assay Development
8.4.2. Contract Testing
8.4.3. Validation And Training
9. Pathogen Screening Kits Market, by Pathogen Type
9.1. Introduction
9.2. Bacteria
9.2.1. Antimicrobial Resistance Detection
9.2.2. Bloodstream Bacteria
9.2.3. Foodborne Bacteria
9.2.4. Respiratory Bacteria
9.3. Fungi
9.3.1. Molds
9.3.2. Yeasts
9.4. Parasites
9.4.1. Helminths
9.4.2. Protozoa
9.5. Viruses
9.5.1. Bloodborne Viruses
9.5.2. Enteric Viruses
9.5.3. Respiratory Viruses
9.5.4. Vector Borne Viruses
10. Pathogen Screening Kits Market, by Sample Type
10.1. Introduction
10.2. Blood
10.2.1. Plasma
10.2.2. Serum
10.2.3. Whole Blood
10.3. Environmental Samples
10.4. Food Samples
10.4.1. Dairy
10.4.2. Meat
10.4.3. Produce
10.5. Stool
10.6. Swabs
10.6.1. Nasal
10.6.2. Nasopharyngeal
10.6.3. Oropharyngeal
10.7. Urine
11. Pathogen Screening Kits Market, by Test Format
11.1. Introduction
11.2. High Throughput Automated
11.2.1. 384 Well Platforms
11.2.2. 96 Well Platforms
11.2.3. Automated NGS Workflows
11.3. Integrated Systems
11.3.1. Closed Systems
11.3.2. Open Systems
11.4. Kit Based
11.4.1. Multiplex Panels
11.4.2. Single Analyte Kits
11.5. Point Of Care Rapid Tests
11.5.1. Lateral Flow Tests
11.5.2. Portable Molecular Platforms
12. Pathogen Screening Kits Market, by Automation Level
12.1. Introduction
12.2. Fully Automated
12.3. Manual
12.4. Semi Automated
13. Pathogen Screening Kits Market, by Application
13.1. Introduction
13.2. Biodefense
13.2.1. Emergency Response
13.2.2. Surveillance Programs
13.3. Blood Screening
13.3.1. Donor Screening
13.3.2. Transfusion Safety
13.4. Food Testing
13.4.1. Dairy
13.4.2. Meat And Poultry
13.4.3. Processed Foods
13.4.4. Produce
13.5. Infectious Diseases
13.5.1. Bloodstream And Sepsis
13.5.2. Central Nervous System
13.5.3. Gastrointestinal And Foodborne
13.5.4. Respiratory
13.5.5. Sexually Transmitted Infections
13.5.6. Vector Borne
13.6. Veterinary
13.6.1. Companion Animals
13.6.2. Livestock
13.6.3. Poultry
13.7. Water Testing
13.7.1. Drinking Water
13.7.2. Recreational Water
13.7.3. Wastewater
14. Pathogen Screening Kits Market, by End User
14.1. Introduction
14.2. Diagnostic Laboratories
14.2.1. Clinical Laboratories
14.2.2. Independent Laboratories
14.2.3. Reference Laboratories
14.3. Food Testing Laboratories
14.4. Hospitals And Clinics
14.4.1. Inpatient
14.4.2. Outpatient
14.5. Pharmaceutical And Biotechnology
14.5.1. Quality Control
14.5.2. R And D
14.6. Point Of Care Settings
14.7. Research Institutes
14.8. Veterinary Clinics
15. Pathogen Screening Kits Market, by Sales Channel
15.1. Introduction
15.2. Direct Sales
15.3. Distributor Partners
15.4. E Commerce
16. Pathogen Screening Kits Market, by Region
16.1. Introduction
16.2. Asia-Pacific
16.3. North America
16.4. Latin America
16.5. Europe
16.6. Middle East
16.7. Africa
17. Pathogen Screening Kits Market, by Group
17.1. Introduction
17.2. ASEAN
17.3. GCC
17.4. European Union
17.5. BRICS
17.6. G7
17.7. NATO
18. Pathogen Screening Kits Market, by Country
18.1. Introduction
18.2. United States
18.3. Canada
18.4. Mexico
18.5. Brazil
18.6. United Kingdom
18.7. Germany
18.8. France
18.9. Russia
18.10. Italy
18.11. Spain
18.12. China
18.13. India
18.14. Japan
18.15. Australia
18.16. South Korea
19. Competitive Landscape
19.1. Market Share Analysis, 2025
19.2. Market Concentration Analysis, 2025
19.2.1. Concentration Ratio (CR)
19.2.2. Herfindahl Hirschman Index (HHI)
19.3. Recent Developments & Impact Analysis, 2025
19.4. Product Portfolio Analysis, 2025
19.5. Benchmarking Analysis, 2025
20. Company Profiles
20.1. 3M Company
20.2. Abbott Laboratories
20.3. Agilent Technologies Inc
20.4. Becton Dickinson and Company
20.5. Bio-Rad Laboratories Inc
20.6. bioMérieux SA
20.7. Charles River Laboratories Inc
20.8. Charm Sciences Inc
20.9. Danaher Corporation
20.10. Eurofins Scientific
20.11. F. Hoffmann-La Roche Ltd
20.12. Hologic Inc
20.13. IDEXX Laboratories Inc
20.14. Luminex Corporation
20.15. Merck KGaA
20.16. Neogen Corporation
20.17. PathogenDx Inc
20.18. PerkinElmer Inc
20.19. Qiagen N.V.
20.20. Quest Diagnostics Incorporated
20.21. QuidelOrtho Corporation
20.22. R-Biopharm AG
20.23. Siemens Healthineers AG
20.24. Sysmex Corporation
20.25. Thermo Fisher Scientific Inc
21. Key Experts
LIST OF FIGURES
FIGURE 1. Global Pathogen Screening Kits Market, Years Considered for the Study
FIGURE 2. Global Pathogen Screening Kits Market, Research Design
FIGURE 3. Global Pathogen Screening Kits Market, Research Framework
FIGURE 4. Global Pathogen Screening Kits Market, Data Triangulation
FIGURE 5. Global Pathogen Screening Kits Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Pathogen Screening Kits Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global Pathogen Screening Kits Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Pathogen Screening Kits Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Pathogen Screening Kits Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Pathogen Screening Kits Market Size, by Pathogen Type, 2025 vs 2032 (%)
FIGURE 11. Global Pathogen Screening Kits Market Size, by Pathogen Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Pathogen Screening Kits Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 13. Global Pathogen Screening Kits Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Pathogen Screening Kits Market Size, by Test Format, 2025 vs 2032 (%)
FIGURE 15. Global Pathogen Screening Kits Market Size, by Test Format, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Pathogen Screening Kits Market Size, by Automation Level, 2025 vs 2032 (%)
FIGURE 17. Global Pathogen Screening Kits Market Size, by Automation Level, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Pathogen Screening Kits Market Size, by Application, 2025 vs 2032 (%)
FIGURE 19. Global Pathogen Screening Kits Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Pathogen Screening Kits Market Size, by End User, 2025 vs 2032 (%)
FIGURE 21. Global Pathogen Screening Kits Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Pathogen Screening Kits Market Size, by Sales Channel, 2025 vs 2032 (%)
FIGURE 23. Global Pathogen Screening Kits Market Size, by Sales Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global Pathogen Screening Kits Market Size, by Region, 2025 vs 2032 (%)
FIGURE 25. Global Pathogen Screening Kits Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 26. Global Pathogen Screening Kits Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 27. Global Pathogen Screening Kits Market Size, by Country, 2025 vs 2032 (%)
FIGURE 28. Global Pathogen Screening Kits Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 29. Global Pathogen Screening Kits Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Pathogen Screening Kits Market Segmentation & Coverage
TABLE 2. Global Pathogen Screening Kits Market Size, 2017-2032 (USD Million)
TABLE 3. Global Pathogen Screening Kits Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Culture Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Culture Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Culture Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Culture Enrichment Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Culture Enrichment Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Culture Enrichment Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Selective Media Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Selective Media Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Selective Media Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Immunoassay Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Immunoassay Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Immunoassay Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Chemiluminescent Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Chemiluminescent Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Chemiluminescent Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Enzyme Linked Immunosorbent Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Enzyme Linked Immunosorbent Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Enzyme Linked Immunosorbent Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Lateral Flow Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Lateral Flow Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Lateral Flow Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Isothermal Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Isothermal Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Isothermal Amplification Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Helicase Dependent Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Helicase Dependent Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Helicase Dependent Amplification Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Loop Mediated Isothermal Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Loop Mediated Isothermal Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Loop Mediated Isothermal Amplification Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Recombinase Polymerase Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Recombinase Polymerase Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Recombinase Polymerase Amplification Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Mass Spectrometry Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Mass Spectrometry Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Mass Spectrometry Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global LC MS MS Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global LC MS MS Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global LC MS MS Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global MALDI TOF Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global MALDI TOF Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global MALDI TOF Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Microarray Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Microarray Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Microarray Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global DNA Microarray Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global DNA Microarray Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global DNA Microarray Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Protein Microarray Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Protein Microarray Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Protein Microarray Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Next Generation Sequencing Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Next Generation Sequencing Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Next Generation Sequencing Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Amplicon Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Amplicon Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Amplicon Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Shotgun Metagenomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Shotgun Metagenomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Shotgun Metagenomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Targeted Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Targeted Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Targeted Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global PCR Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global PCR Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global PCR Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Digital PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Digital PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Digital PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Quantitative PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Quantitative PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Quantitative PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Real Time PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Real Time PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Real Time PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Reverse Transcription PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Reverse Transcription PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Reverse Transcription PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Pathogen Screening Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 83. Global Consumables And Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Consumables And Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Consumables And Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Controls And Standards Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Controls And Standards Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Controls And Standards Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Enzymes And Master Mixes Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Enzymes And Master Mixes Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Enzymes And Master Mixes Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Extraction Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Extraction Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Extraction Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Reagent Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Reagent Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Reagent Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Instruments And Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Instruments And Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Instruments And Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Automated Extraction Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Automated Extraction Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Automated Extraction Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Lateral Flow Readers Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Lateral Flow Readers Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Lateral Flow Readers Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Real Time PCR Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Real Time PCR Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Real Time PCR Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Sequencers Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Thermal Cyclers Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Thermal Cyclers Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Thermal Cyclers Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Assay Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Assay Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Assay Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Contract Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Contract Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Contract Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Validation And Training Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Validation And Training Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Validation And Training Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Pathogen Screening Kits Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 129. Global Bacteria Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Global Bacteria Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. Global Bacteria Market Size, by Country, 2017-2032 (USD Million)
TABLE 132. Global Antimicrobial Resistance Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global Antimicrobial Resistance Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global Antimicrobial Resistance Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Bloodstream Bacteria Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Global Bloodstream Bacteria Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. Global Bloodstream Bacteria Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. Global Foodborne Bacteria Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Global Foodborne Bacteria Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. Global Foodborne Bacteria Market Size, by Country, 2017-2032 (USD Million)
TABLE 141. Global Respiratory Bacteria Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Global Respiratory Bacteria Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. Global Respiratory Bacteria Market Size, by Country, 2017-2032 (USD Million)
TABLE 144. Global Fungi Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Global Fungi Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. Global Fungi Market Size, by Country, 2017-2032 (USD Million)
TABLE 147. Global Molds Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Global Molds Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. Global Molds Market Size, by Country, 2017-2032 (USD Million)
TABLE 150. Global Yeasts Market Size, by Region, 2017-2032 (USD Million)
TABLE 151. Global Yeasts Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. Global Yeasts Market Size, by Country, 2017-2032 (USD Million)
TABLE 153. Global Parasites Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Global Parasites Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. Global Parasites Market Size, by Country, 2017-2032 (USD Million)
TABLE 156. Global Helminths Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Global Helminths Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. Global Helminths Market Size, by Country, 2017-2032 (USD Million)
TABLE 159. Global Protozoa Market Size, by Region, 2017-2032 (USD Million)
TABLE 160. Global Protozoa Market Size, by Group, 2017-2032 (USD Million)
TABLE 161. Global Protozoa Market Size, by Country, 2017-2032 (USD Million)
TABLE 162. Global Viruses Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Global Viruses Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. Global Viruses Market Size, by Country, 2017-2032 (USD Million)
TABLE 165. Global Bloodborne Viruses Market Size, by Region, 2017-2032 (USD Million)
TABLE 166. Global Bloodborne Viruses Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. Global Bloodborne Viruses Market Size, by Country, 2017-2032 (USD Million)
TABLE 168. Global Enteric Viruses Market Size, by Region, 2017-2032 (USD Million)
TABLE 169. Global Enteric Viruses Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. Global Enteric Viruses Market Size, by Country, 2017-2032 (USD Million)
TABLE 171. Global Respiratory Viruses Market Size, by Region, 2017-2032 (USD Million)
TABLE 172. Global Respiratory Viruses Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. Global Respiratory Viruses Market Size, by Country, 2017-2032 (USD Million)
TABLE 174. Global Vector Borne Viruses Market Size, by Region, 2017-2032 (USD Million)
TABLE 175. Global Vector Borne Viruses Market Size, by Group, 2017-2032 (USD Million)
TABLE 176. Global Vector Borne Viruses Market Size, by Country, 2017-2032 (USD Million)
TABLE 177. Global Pathogen Screening Kits Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 178. Global Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 179. Global Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 180. Global Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 181. Global Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 182. Global Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 183. Global Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 184. Global Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 185. Global Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 186. Global Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 187. Global Whole Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 188. Global Whole Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 189. Global Whole Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 190. Global Environmental Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 191. Global Environmental Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 192. Global Environmental Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 193. Global Food Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 194. Global Food Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 195. Global Food Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 196. Global Dairy Market Size, by Region, 2017-2032 (USD Million)
TABLE 197. Global Dairy Market Size, by Group, 2017-2032 (USD Million)
TABLE 198. Global Dairy Market Size, by Country, 2017-2032 (USD Million)
TABLE 199. Global Meat Market Size, by Region, 2017-2032 (USD Million)
TABLE 200. Global Meat Market Size, by Group, 2017-2032 (USD Million)
TABLE 201. Global Meat Market Size, by Country, 2017-2032 (USD Million)
TABLE 202. Global Produce Market Size, by Region, 2017-2032 (USD Million)
TABLE 203. Global Produce Market Size, by Group, 2017-2032 (USD Million)
TABLE 204. Global Produce Market Size, by Country, 2017-2032 (USD Million)
TABLE 205. Global Stool Market Size, by Region, 2017-2032 (USD Million)
TABLE 206. Global Stool Market Size, by Group, 2017-2032 (USD Million)
TABLE 207. Global Stool Market Size, by Country, 2017-2032 (USD Million)
TABLE 208. Global Swabs Market Size, by Region, 2017-2032 (USD Million)
TABLE 209. Global Swabs Market Size, by Group, 2017-2032 (USD Million)
TABLE 210. Global Swabs Market Size, by Country, 2017-2032 (USD Million)
TABLE 211. Global Nasal Market Size, by Region, 2017-2032 (USD Million)
TABLE 212. Global Nasal Market Size, by Group, 2017-2032 (USD Million)
TABLE 213. Global Nasal Market Size, by Country, 2017-2032 (USD Million)
TABLE 214. Global Nasopharyngeal Market Size, by Region, 2017-2032 (USD Million)
TABLE 215. Global Nasopharyngeal Market Size, by Group, 2017-2032 (USD Million)
TABLE 216. Global Nasopharyngeal Market Size, by Country, 2017-2032 (USD Million)
TABLE 217. Global Oropharyngeal Market Size, by Region, 2017-2032 (USD Million)
TABLE 218. Global Oropharyngeal Market Size, by Group, 2017-2032 (USD Million)
TABLE 219. Global Oropharyngeal Market Size, by Country, 2017-2032 (USD Million)
TABLE 220. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 221. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 222. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 223. Global Pathogen Screening Kits Market Size, by Test Format, 2017-2032 (USD Million)
TABLE 224. Global High Throughput Automated Market Size, by Region, 2017-2032 (USD Million)
TABLE 225. Global High Throughput Automated Market Size, by Group, 2017-2032 (USD Million)
TABLE 226. Global High Throughput Automated Market Size, by Country, 2017-2032 (USD Million)
TABLE 227. Global 384 Well Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 228. Global 384 Well Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 229. Global 384 Well Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 230. Global 96 Well Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 231. Global 96 Well Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 232. Global 96 Well Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 233. Global Automated NGS Workflows Market Size, by Region, 2017-2032 (USD Million)
TABLE 234. Global Automated NGS Workflows Market Size, by Group, 2017-2032 (USD Million)
TABLE 235. Global Automated NGS Workflows Market Size, by Country, 2017-2032 (USD Million)
TABLE 236. Global Integrated Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 237. Global Integrated Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 238. Global Integrated Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 239. Global Closed Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 240. Global Closed Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 241. Global Closed Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 242. Global Open Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 243. Global Open Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 244. Global Open Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 245. Global Kit Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 246. Global Kit Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 247. Global Kit Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 248. Global Multiplex Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 249. Global Multiplex Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 250. Global Multiplex Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 251. Global Single Analyte Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 252. Global Single Analyte Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 253. Global Single Analyte Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 254. Global Point Of Care Rapid Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 255. Global Point Of Care Rapid Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 256. Global Point Of Care Rapid Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 257. Global Lateral Flow Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 258. Global Lateral Flow Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 259. Global Lateral Flow Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 260. Global Portable Molecular Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 261. Global Portable Molecular Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 262. Global Portable Molecular Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 263. Global Pathogen Screening Kits Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 264. Global Fully Automated Market Size, by Region, 2017-2032 (USD Million)
TABLE 265. Global Fully Automated Market Size, by Group, 2017-2032 (USD Million)
TABLE 266. Global Fully Automated Market Size, by Country, 2017-2032 (USD Million)
TABLE 267. Global Manual Market Size, by Region, 2017-2032 (USD Million)
TABLE 268. Global Manual Market Size, by Group, 2017-2032 (USD Million)
TABLE 269. Global Manual Market Size, by Country, 2017-2032 (USD Million)
TABLE 270. Global Semi Automated Market Size, by Region, 2017-2032 (USD Million)
TABLE 271. Global Semi Automated Market Size, by Group, 2017-2032 (USD Million)
TABLE 272. Global Semi Automated Market Size, by Country, 2017-2032 (USD Million)
TABLE 273. Global Pathogen Screening Kits Market Size, by Application, 2017-2032 (USD Million)
TABLE 274. Global Biodefense Market Size, by Region, 2017-2032 (USD Million)
TABLE 275. Global Biodefense Market Size, by Group, 2017-2032 (USD Million)
TABLE 276. Global Biodefense Market Size, by Country, 2017-2032 (USD Million)
TABLE 277. Global Emergency Response Market Size, by Region, 2017-2032 (USD Million)
TABLE 278. Global Emergency Response Market Size, by Group, 2017-2032 (USD Million)
TABLE 279. Global Emergency Response Market Size, by Country, 2017-2032 (USD Million)
TABLE 280. Global Surveillance Programs Market Size, by Region, 2017-2032 (USD Million)
TABLE 281. Global Surveillance Programs Market Size, by Group, 2017-2032 (USD Million)
TABLE 282. Global Surveillance Programs Market Size, by Country, 2017-2032 (USD Million)
TABLE 283. Global Blood Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 284. Global Blood Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 285. Global Blood Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 286. Global Donor Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 287. Global Donor Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 288. Global Donor Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 289. Global Transfusion Safety Market Size, by Region, 2017-2032 (USD Million)
TABLE 290. Global Transfusion Safety Market Size, by Group, 2017-2032 (USD Million)
TABLE 291. Global Transfusion Safety Market Size, by Country, 2017-2032 (USD Million)
TABLE 292. Global Food Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 293. Global Food Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 294. Global Food Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 295. Global Dairy Market Size, by Region, 2017-2032 (USD Million)
TABLE 296. Global Dairy Market Size, by Group, 2017-2032 (USD Million)
TABLE 297. Global Dairy Market Size, by Country, 2017-2032 (USD Million)
TABLE 298. Global Meat And Poultry Market Size, by Region, 2017-2032 (USD Million)
TABLE 299. Global Meat And Poultry Market Size, by Group, 2017-2032 (USD Million)
TABLE 300. Global Meat And Poultry Market Size, by Country, 2017-2032 (USD Million)
TABLE 301. Global Processed Foods Market Size, by Region, 2017-2032 (USD Million)
TABLE 302. Global Processed Foods Market Size, by Group, 2017-2032 (USD Million)
TABLE 303. Global Processed Foods Market Size, by Country, 2017-2032 (USD Million)
TABLE 304. Global Produce Market Size, by Region, 2017-2032 (USD Million)
TABLE 305. Global Produce Market Size, by Group, 2017-2032 (USD Million)
TABLE 306. Global Produce Market Size, by Country, 2017-2032 (USD Million)
TABLE 307. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 308. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 309. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 310. Global Bloodstream And Sepsis Market Size, by Region, 2017-2032 (USD Million)
TABLE 311. Global Bloodstream And Sepsis Market Size, by Group, 2017-2032 (USD Million)
TABLE 312. Global Bloodstream And Sepsis Market Size, by Country, 2017-2032 (USD Million)
TABLE 313. Global Central Nervous System Market Size, by Region, 2017-2032 (USD Million)
TABLE 314. Global Central Nervous System Market Size, by Group, 2017-2032 (USD Million)
TABLE 315. Global Central Nervous System Market Size, by Country, 2017-2032 (USD Million)
TABLE 316. Global Gastrointestinal And Foodborne Market Size, by Region, 2017-2032 (USD Million)
TABLE 317. Global Gastrointestinal And Foodborne Market Size, by Group, 2017-2032 (USD Million)
TABLE 318. Global Gastrointestinal And Foodborne Market Size, by Country, 2017-2032 (USD Million)
TABLE 319. Global Respiratory Market Size, by Region, 2017-2032 (USD Million)
TABLE 320. Global Respiratory Market Size, by Group, 2017-2032 (USD Million)
TABLE 321. Global Respiratory Market Size, by Country, 2017-2032 (USD Million)
TABLE 322. Global Sexually Transmitted Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 323. Global Sexually Transmitted Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 324. Global Sexually Transmitted Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 325. Global Vector Borne Market Size, by Region, 2017-2032 (USD Million)
TABLE 326. Global Vector Borne Market Size, by Group, 2017-2032 (USD Million)
TABLE 327. Global Vector Borne Market Size, by Country, 2017-2032 (USD Million)
TABLE 328. Global Veterinary Market Size, by Region, 2017-2032 (USD Million)
TABLE 329. Global Veterinary Market Size, by Group, 2017-2032 (USD Million)
TABLE 330. Global Veterinary Market Size, by Country, 2017-2032 (USD Million)
TABLE 331. Global Companion Animals Market Size, by Region, 2017-2032 (USD Million)
TABLE 332. Global Companion Animals Market Size, by Group, 2017-2032 (USD Million)
TABLE 333. Global Companion Animals Market Size, by Country, 2017-2032 (USD Million)
TABLE 334. Global Livestock Market Size, by Region, 2017-2032 (USD Million)
TABLE 335. Global Livestock Market Size, by Group, 2017-2032 (USD Million)
TABLE 336. Global Livestock Market Size, by Country, 2017-2032 (USD Million)
TABLE 337. Global Poultry Market Size, by Region, 2017-2032 (USD Million)
TABLE 338. Global Poultry Market Size, by Group, 2017-2032 (USD Million)
TABLE 339. Global Poultry Market Size, by Country, 2017-2032 (USD Million)
TABLE 340. Global Water Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 341. Global Water Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 342. Global Water Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 343. Global Drinking Water Market Size, by Region, 2017-2032 (USD Million)
TABLE 344. Global Drinking Water Market Size, by Group, 2017-2032 (USD Million)
TABLE 345. Global Drinking Water Market Size, by Country, 2017-2032 (USD Million)
TABLE 346. Global Recreational Water Market Size, by Region, 2017-2032 (USD Million)
TABLE 347. Global Recreational Water Market Size, by Group, 2017-2032 (USD Million)
TABLE 348. Global Recreational Water Market Size, by Country, 2017-2032 (USD Million)
TABLE 349. Global Wastewater Market Size, by Region, 2017-2032 (USD Million)
TABLE 350. Global Wastewater Market Size, by Group, 2017-2032 (USD Million)
TABLE 351. Global Wastewater Market Size, by Country, 2017-2032 (USD Million)
TABLE 352. Global Pathogen Screening Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 353. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 354. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 355. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 356. Global Clinical Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 357. Global Clinical Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 358. Global Clinical Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 359. Global Independent Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 360. Global Independent Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 361. Global Independent Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 362. Global Reference Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 363. Global Reference Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 364. Global Reference Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 365. Global Food Testing Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 366. Global Food Testing Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 367. Global Food Testing Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 368. Global Hospitals And Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 369. Global Hospitals And Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 370. Global Hospitals And Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 371. Global Inpatient Market Size, by Region, 2017-2032 (USD Million)
TABLE 372. Global Inpatient Market Size, by Group, 2017-2032 (USD Million)
TABLE 373. Global Inpatient Market Size, by Country, 2017-2032 (USD Million)
TABLE 374. Global Outpatient Market Size, by Region, 2017-2032 (USD Million)
TABLE 375. Global Outpatient Market Size, by Group, 2017-2032 (USD Million)
TABLE 376. Global Outpatient Market Size, by Country, 2017-2032 (USD Million)
TABLE 377. Global Pharmaceutical And Biotechnology Market Size, by Region, 2017-2032 (USD Million)
TABLE 378. Global Pharmaceutical And Biotechnology Market Size, by Group, 2017-2032 (USD Million)
TABLE 379. Global Pharmaceutical And Biotechnology Market Size, by Country, 2017-2032 (USD Million)
TABLE 380. Global Quality Control Market Size, by Region, 2017-2032 (USD Million)
TABLE 381. Global Quality Control Market Size, by Group, 2017-2032 (USD Million)
TABLE 382. Global Quality Control Market Size, by Country, 2017-2032 (USD Million)
TABLE 383. Global R And D Market Size, by Region, 2017-2032 (USD Million)
TABLE 384. Global R And D Market Size, by Group, 2017-2032 (USD Million)
TABLE 385. Global R And D Market Size, by Country, 2017-2032 (USD Million)
TABLE 386. Global Point Of Care Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 387. Global Point Of Care Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 388. Global Point Of Care Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 389. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 390. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 391. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 392. Global Veterinary Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 393. Global Veterinary Clinics Market Size, by Group, 2017-2032 (USD Million)
TAB

Companies Mentioned

  • 3M Company
  • Abbott Laboratories
  • Agilent Technologies Inc
  • Becton Dickinson and Company
  • Bio-Rad Laboratories Inc
  • bioMérieux SA
  • Charles River Laboratories Inc
  • Charm Sciences Inc
  • Danaher Corporation
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd
  • Hologic Inc
  • IDEXX Laboratories Inc
  • Luminex Corporation
  • Merck KGaA
  • Neogen Corporation
  • PathogenDx Inc
  • PerkinElmer Inc
  • Qiagen N.V.
  • Quest Diagnostics Incorporated
  • QuidelOrtho Corporation
  • R-Biopharm AG
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc

Related Reports

Infectious Diseases In-Vitro Diagnostics Market - Global Forecast 2026-2032 - Product Image

Infectious Diseases In-Vitro Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Blood Transfusion Diagnostics Market - Global Forecast 2026-2032 - Product Image

Blood Transfusion Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Microbial Identification Market - Global Forecast 2026-2032 - Product Image

Microbial Identification Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Sexually Transmitted Infection Diagnostics Kit Market - Global Forecast 2026-2032 - Product Image

Sexually Transmitted Infection Diagnostics Kit Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Polymerase Chain Reaction Market - Global Forecast 2026-2032 - Product Image

Polymerase Chain Reaction Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.